These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34358693)

  • 1. Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road.
    Kadriu B; Musazzi L; Johnston JN; Kalynchuk LE; Caruncho HJ; Popoli M; Zarate CA
    Drug Discov Today; 2021 Dec; 26(12):2816-2838. PubMed ID: 34358693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
    Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
    Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
    Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
    Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
    Nguyen L; Matsumoto RR
    Behav Brain Res; 2015 Dec; 295():26-34. PubMed ID: 25804358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
    Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC
    J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit.
    Yao N; Skiteva O; Zhang X; Svenningsson P; Chergui K
    Mol Psychiatry; 2018 Oct; 23(10):2066-2077. PubMed ID: 29158578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: central mediators of pathophysiology and antidepressant activity?
    Freudenberg F; Celikel T; Reif A
    Neurosci Biobehav Rev; 2015 May; 52():193-206. PubMed ID: 25783220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
    Zanos P; Moaddel R; Morris PJ; Georgiou P; Fischell J; Elmer GI; Alkondon M; Yuan P; Pribut HJ; Singh NS; Dossou KS; Fang Y; Huang XP; Mayo CL; Wainer IW; Albuquerque EX; Thompson SM; Thomas CJ; Zarate CA; Gould TD
    Nature; 2016 May; 533(7604):481-6. PubMed ID: 27144355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
    Lees GJ
    Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.
    Cavalleri L; Merlo Pich E; Millan MJ; Chiamulera C; Kunath T; Spano PF; Collo G
    Mol Psychiatry; 2018 Apr; 23(4):812-823. PubMed ID: 29158584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders.
    Reuillon T; Ward SE; Beswick P
    Curr Top Med Chem; 2016; 16(29):3536-3565. PubMed ID: 27363568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors.
    Li JM; Liu LL; Su WJ; Wang B; Zhang T; Zhang Y; Jiang CL
    Neuropharmacology; 2019 Mar; 146():149-153. PubMed ID: 30496753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism.
    Aleksandrova LR; Phillips AG; Wang YT
    J Psychiatry Neurosci; 2017 Jun; 42(4):222-229. PubMed ID: 28234212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
    Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments.
    Kadriu B; Musazzi L; Henter ID; Graves M; Popoli M; Zarate CA
    Int J Neuropsychopharmacol; 2019 Feb; 22(2):119-135. PubMed ID: 30445512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine-induced inhibition of glycogen synthase kinase-3 contributes to the augmentation of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor signaling.
    Beurel E; Grieco SF; Amadei C; Downey K; Jope RS
    Bipolar Disord; 2016 Sep; 18(6):473-480. PubMed ID: 27687706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low-dose ketamine combined with propofol on phosphorylation of AMPA receptor GluR1 subunit and GABAA receptor in hippocampus of stressed rats receiving electroconvulsive shock.
    Chen J; Peng LH; Luo J; Liu L; Lv F; Li P; Ao L; Hao XC; Min S
    J ECT; 2015 Mar; 31(1):50-6. PubMed ID: 24831997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug.
    Pałucha-Poniewiera A
    Pharmacol Rep; 2018 Oct; 70(5):837-846. PubMed ID: 30086517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine disrupts neuromodulatory control of glutamatergic synaptic transmission.
    Lur G; Fariborzi M; Higley MJ
    PLoS One; 2019; 14(3):e0213721. PubMed ID: 30865708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension tests.
    Andreasen JT; Gynther M; Rygaard A; Bøgelund T; Nielsen SD; Clausen RP; Mogensen J; Pickering DS
    Neurosci Lett; 2013 Jun; 546():6-10. PubMed ID: 23643996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.